Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for prevention of chest infection hospitalisations in children with neurological impairment
ACTRN12619001597189Phase 3Terminated
- Sponsor
- University of Liverpool
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in pulmonary infection comparing Azithromycin with Placebo (2 arms). Primary endpoint: Proportion of children hospitalised with lower respiratory tract infection over 52 weeks. Started Jul 2020; status: terminated.
02
Drugs
azithromycin
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ACTRN12619001597189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001597189.